Business Context and Reporting Period
Company: SANUWAVE Health, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: January 10, 2018
Reporting Period: The filing reports on the final closing of a convertible note offering that occurred on January 10, 2018, concluding a series of closings that began in November 2017.
Key Financial Metrics
This filing details a capital raise via 10% Convertible Promissory Notes. The total aggregate principal amount raised across all closings is $2,899,750, broken down as follows:
- November 3, 2017 Closing: $1,124,440
- November 30, 2017 Closing: $245,000
- December 21, 2017 Closing: $150,000
- January 10, 2018 Closing (Final): $1,380,310
Instrument Terms:
- Interest Rate: 10% per annum.
- Term: Six months from the subscription date.
- Conversion Price: $0.11 per share of Common Stock.
- Warrants Issued: Class N Warrants issued at a 1:1 ratio to principal (based on $0.11 strike), expiring March 17, 2019. Total warrants issued in this series: 26,361,362.
Use of Proceeds: Working capital and general corporate purposes.
Note: This filing does not provide revenue, profit, cash flow, or margin data. It focuses solely on the debt issuance.
Material Changes and Related Party Transactions
The primary material change is the increase in debt obligations and potential equity dilution due to the issuance of the notes and warrants described above. A related party transaction was disclosed:
- Purchaser: Premier Shockwave Inc., owned by Anthony Michael Stolarski (Board Member and existing shareholder).
- Amount: $330,000 aggregate principal amount of the 10% Convertible Promissory Notes.
Guidance, Risks, and Contingencies
Registration Rights Obligation: The Company is required to file a registration statement covering shares issuable upon conversion of the notes or exercise of warrants. Failure to meet specific deadlines in the Registration Rights Agreement may result in monetary penalties.
Forward-Looking Statements: The filing includes a cautionary statement regarding forward-looking information, noting that actual results may differ materially due to risks and uncertainties. The Company assumes no obligation to update these statements.
Regulatory Status: The issuance was exempt from registration under Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D. No general solicitation or advertising was used.
Investor Verification Checklist
- Verify the Company's ability to meet the registration statement deadlines to avoid monetary penalties under the Registration Rights Agreement.
- Assess the potential dilution impact of converting $2,899,750 in principal plus accrued interest at the $0.11 conversion price.
- Confirm the Company's cash burn rate and whether the raised capital is sufficient for the stated working capital needs.
- Review the related party transaction with Premier Shockwave Inc. for any additional undisclosed terms or conflicts of interest.
- Check subsequent filings for the actual filing of the required registration statement for the underlying shares.